Amgen is committed to unlocking the potential of biology for patients suffering from serious illnesses by discovering, developing, manufacturing and delivering innovative human therapeutics. This approach begins by using tools like advanced human genetics to unravel the complexities of disease and understand the fundamentals of human biology.

Amgen focuses on areas of high unmet medical need and leverages its biologics manufacturing expertise to uncover solutions that improve health outcomes and dramatically improve people’s lives. A biotechnology pioneer for 40 years, Amgen has grown to be one of the world’s leading biotechnology companies and has reached millions of patients around the world with a pipeline of medicines with breakaway potential.

© 2020 Singapore Heart Foundation.

Powered By: